Abstract
Heart failure (HF) is a major and costly public health concern, and its prognosis is grim—with high hospitalization and mortality rates. It is well documented that HF patients experience disproportionately high rates of depression and that depressed HF patients have worse clinical outcomes than their non-depressed counterparts. The purpose of this chapter is to introduce the reader to the study of depression in HF, and how psychoneuroimmunologic principals have been applied to further elucidate the mechanisms (i.e., neurohormonal and cytokine activation) linking these co-morbid disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kent LK, Shapiro PA (2009) Depression and related psychological factors in heart disease. Harv Rev Psychiatry 17:377–388
Norra C, Skobel EC, Arndt M et al (2008) High impact of depression in heart failure: early diagnosis and treatment options. Int J Cardiol 125:220–231
Watson K, Summer KM (2009) Depression in patients with heart failure: clinical implications and management. Pharmacotherapy 29:49–63
Shapiro P (2009) Treatment of depression in patients with congestive heart failure. Heart Fail Rev 14:7–12
Williams SA, Kasl SV, Heiat A et al (2002) Depression and risk of heart failure among the elderly: a prospective community-based study. Psychosom Med 64:6–12
Abramson J, Berger A, Krumholz HM et al (2001) Depression and risk of heart failure among older persons with isolated systolic hypertension. Arch Intern Med 161:1725–1730
Bui AL, Horwich TB, Fonarow GC (2010) Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8:30–41
Roger VL, Go AS, Lloyd-Jones DM et al (2010) Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation 123:18–209
Levy D, Kenchaiah S, Larson MG et al (2002) Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347:1397–1402
DeFrances CJ et al (2008) 2006 National hospital discharge survey. Natl Health Stat Report 5:1–20
Lloyd-Jones D, Adams RJ, Brown TM et al (2010) Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation 121:e46–e215
Hunt SA, Abraham WT, Chin MH et al (2009) 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53:e1–e90
Bristow MR (2000) ß-adrenergic receptor blockade in chronic heart failure. Circulation 101:558–569
Rutledge T, Reis VA, Linke SE et al (2006) Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 48:1527–1537
Kessler RC, Berglund P, Demler O et al (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289:3095–3105
Gottlieb SS, Khatta M, Friedmann E et al (2004) The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol 43:1542–1549
Havranek EP, Spertus JA, Masoudi FA et al (2004) Predictors of the onset of depressive symptoms in patients with heart failure. J Am Coll Cardiol 44:2333–2338
Tousoulis D, Antonopoulos AS, Antoniades C et al (2010) Role of depression in heart failure—choosing the right antidepressive treatment. Int J Cardiol 140:12–18
Sherwood A, Blumenthal JA, Trivedi R et al (2007) Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med 167:367–373
Jiang W, Alexander J, Christopher E et al (2001) Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 161:1849–1856
Jiang W, Kuchibhatla M, Clary GL et al (2007) Relationship between depressive symptoms and long-term mortality in patients with heart failure. Am Heart J 154:102–108
Vaccarino V, Kasl SV, Abramson J et al (2001) Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 38:199–205
Frasure-Smith N, Lesperance F, Habra M et al (2009) Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure. Circulation 120:134–140
Sherwood A, Blumenthal JA, Hinderliter AL et al (2011) Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure. J Am Coll Cardiol 57:418–423
Sullivan M, Levy WC, Russo JE et al (2004) Depression and health status in patients with advanced heart failure: a prospective study in tertiary care. J Card Fail 10:390–396
Jiang W, Kuchibhatla M, Cuffe MS et al (2004) Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation 110:3452–3456
Hallas CN, Wray J, Andreou P et al (2011) Depression and perceptions about heart failure predict quality of life in patients with advanced heart failure. Heart Lung 40:111–121
Gottlieb SS, Kop WJ, Ellis SJ et al (2009) Relation of depression to severity of illness in heart failure (from Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)). J Am Coll Cardiol 103:1285–1289
Maes M (2001) Psychological stress and the inflammatory response system. Clin Sci 101:193–194
Penninx BW, Kritchevsky SB, Yaffe K et al (2003) Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study. Biol Psychiatry 54:566–572
Bremmer MA, Beekman AT, Deeg DJ et al (2008) Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord 106:249–255
Beck A, Steer RA (1987) Manual for the revised Beck Depression Inventory. Psychological Corportation, San Antonio
Linke SE, Rutledge T, Johnson BD et al (2009) Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: a report from the National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation. Arch Gen Psychiatry 66:499–507
Wirtz PH, Hong S, Redwine LS et al (2009) Depressive symptoms are associated with soluble P-selectin reactivity to acute exercise in heart failure. Biol Psychiatry 65:801–807
Wirtz PH, Redwine LS, Mills PJ (2010) Response regarding inflammation as a predictor of depression in heart failure. Brain Behav Immun 24:174–175
Szabo MC, Butcher EC, McIntyre BW et al (1997) RANTES stimulation of T lymphocyte adhesion and activation: role for LFA-1 and ICAM-3. Eur J Immunol 27:1061–1068
Chen J, Fujimoto C, Vistica BP et al (2006) Active participation of antigen-nonspecific lymphoid cells in immune-mediated inflammation. J Immunol 177:3362–3368
Adamopoulos S, Parissis J, Kroupis C et al (2001) Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. Eur Heart J 22:791–797
Pyo RT, Sui J, Dhume A et al (2006) CXCR4 modulates contractility in adult cardiac myocytes. J Mol Cell Cardiol 41:834–844
Frangogiannis NG, Dewald O, Xia Y et al (2007) Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation 115:584–592
Linden W, Gerin W, Davidson K (2003) Cardiovascular reactivity: status quo and a research agenda for the new millennium. Psychosom Med 65:5–8
Redwine LS, Wirtz PH, Hong S et al (2009) Potential shift from adaptive immune activity to nonspecific inflammatory activation associated with higher depression symptoms in chronic heart failure patients. J Card Fail 15:607–615
Redwine LS, Wirtz PH, Hong S et al (2010) Depression as a potential modulator of beta-adrenergic-associated leukocyte mobilization in heart failure patients. J Am Coll Cardiol 56:1720–1727
Bot A, Smith KA, von Herrath M (2004) Molecular and cellular control of T1/T2 immunity at the interface between antimicrobial defense and immune pathology. DNA Cell Biol 23:341–350
Elenkov IJ (2004) Glucocorticoids and the Th1/Th2 balance. Ann N Y Acad Sci 1024:138–146
Fairweather D, Frisancho-Kiss S, Yusung SA et al (2004) Interferon-γ protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-β1, Interleukin-1β, and Interleukin-4 in the Heart. Am J Pathol 165:1883–1894
Afanasyeva M, Georgakopoulos D, Belardi DF et al (2005) Impaired up-regulation of CD25 on CD4+ T cells in IFN-γ knockout mice is associated with progression of myocarditis to heart failure. Proc Natl Acad Sci USA 102:180–185
Redwine LS, Mills PJ, Hong S et al (2007) Cardiac-related hospitalization and/or death associated with immune dysregulation and symptoms of depression in heart failure patients. Psychosom Med 69:23–29
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Jiménez, J.A., Mills, P.J. (2012). Neuroimmune Mechanisms of Depression in Heart Failure. In: Yan, Q. (eds) Psychoneuroimmunology. Methods in Molecular Biology, vol 934. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-071-7_9
Download citation
DOI: https://doi.org/10.1007/978-1-62703-071-7_9
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-070-0
Online ISBN: 978-1-62703-071-7
eBook Packages: Springer Protocols